Association of Atrial Septal Aneurysm and Shunt Size with Stroke Recurrence and Benefit From Patent Foramen Ovale Closure
JAMA Neurol 79:1175-1179, Mas,J-L.,et al, 2022
Stroke Recurrence in Children with Congenital Heart Disease
Ann Neurol 72:103-111, Rodan, L.,et al, 2012
Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007
Embolic Stroke Due to a Left Atrial Thrombus Two Years After Placement of an Atrial Septal Defect Closure Device
Am J Cardiol 98:1294-1296, Raghu,A.,et al, 2006
Sinus Venous-Type Atrial Septal Defect: A Rare Curable Cause of Recurrent Transient Neurological Deficits
Stroke 37:2385-2386, Cakmak,S.,et al, 2006
Incidence and Clinical Course of Thrombus Formation on Atrial Septal Defect and Patent Foramen Ovale Closure Devices in 1,000 Consecutive Patients
J Am Coll Cardiol 43:302-309, Krumsdorf,U.,et al, 2004
Incidence of Thrombus Formation on the CardioSEAL and the Amplatzer Interatrial Closure Devices
Am J Cardiol 93:426-431, Anzai,H.,et al, 2004
Pseudotumor Cerebri Reversed by Cardiac Septal Defect Repair
Neurol 60:2016-2017, Jicha,G.A. &Suarez,G.A., 2003
Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale
Stroke 33:706-711, Lamy,C.,et al, 2002
Effect on Migraine of Closure of Cardiac Right-to-Left Shunts to Prevent Reucrrence of Decompression Illness or Stroke or for Haemodynamic Reasons
Lancet 356:1648-1651, Wilmshurst,P.T.,et al, 2000
Reduced Penetrance,Variable Expressivity,and Genetic Heterogeneity of Familial Atrial Septal Defects
Circulation 97:2043-2048, Benson,D.W.,et al, 1998
An Electrocardiographic Criterion for Diagnosis of Patent Foramen Ovale Associated with Ischemic Stroke
Stroke 29:1393-1397, Ay,H.,et al, 1998
A Comparison of Surgical & Medical Therapy for Atrial Septal Defect in Adults
NEJM 333:469-473, 5131995., Konstantinides,S.,et al, 1995
Patent Foramen Ovale and Brain Infarct:Echocardiographic Predictors, Recurrence, and Prevention
Stroke 25:782-786, Hanna,J.P.,et al, 1994
Familial Atrioventricular Septal Defect:Possible Genetic Mechanisms
Br Heart J 71:79-81, Kumar,A.,et al, 1994
Cerebral Infarction and Ventricular Septal Defect
Stroke 20:957-958, Shuiab,A., 1989
Paradoxical Gas Embolism in a Scuba Diver with an Atrial Septal Defect
BMJ 293:1277, Wilmshurst,P.T.,et al, 1986
Paradoxical Cerebral Embolism:Eight Cases
Neurol 36:1356-1360, Biller,J.,et al, 1986
Clinically Silent Atrial Septal Defects with Evidence for Cerebral Embolization
Ann Int Med 105:695-697, Harvey,J.R.,et al, 1986
Cerebral Emboli of Paradoxical Origin
Ann Neurol 13:314-319, Jones,H.R.,et al, 1983
A Functional Murmur & Stroke in a Young Adult
Arch Int Med 143:519-521, Alexander,J.,et al, 1983
Lyme Disease: What the Neuroradiologist Needs to Know
AJNR 40:1998-2000, Valand, H.A.,et al, 2019
Clinical Reasoning: Cardioembolic Stroke in a 23-year-old Man with Elbow Contracture
Neurol 90:e172-e176, Roy, B. & Raynor, E., 2018
Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017
Infective Endocarditis
Lancet 387:882-893, Cahill, T.J. & Prendergast, B.D., 2016
Electrophysiological Study with Prophylactic Pacing and Survival in Adults with Myotonic Dystrophy and Conduction System Disease
JAMA 307:1292-1301, Wahbi,K.,et al, 2012
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012
LMNA Cardiomyopathy:Cell Biology and Genetics Meet Clinical Medicine
Disease Models & Mechanisms 4:562-568, Lu,J.T., et al, 2011
Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005
Clinicopath Conf., Penumococcal penumonia with Endocarditis and Endophtlhalmitis
NEJM 348:834-842, Case 7-2003, 2003
Pain in the Neck
Lancet 361:1700, Nicholls,S.,et al, 2003
Desmin Myopathy, a Skeletal Myopathy with Cardiomyopathy Caused by Mutations in the Desmin Gene
NEJM 342:770-780, Dalakas,M.C.,et al, 2000
Cardiac Dysfunction in Neuromuscular Diseases
The Neurologist 6:67-82, Pourmand,R., 2000
Autosomal Dominant Myofibrillar Myopathy with Arrhythmogenic Right Ventricular Cardiomyopathy Linked to Chromosome 10q
Ann Neurol 46:684-692,681, Melberg,A.,et al, 1999
Cardiac Involvement in Genetically Confirmed Facioscapulohumeral Muscular Dystrophy
Neurol 51:1454-1456, Laforet,P.,et al, 1998
Cost Effectiveness of Oral Compared with IV Antibiotic Therapy for Pts with Early Lyme Dis or Lyme Arthritis
NEJM 337:357-363, Eckman,M.H.,et al, 1997
Cardiac Involvement in a Large Kindred with Myotonic Dystrophy:Quant Assess & Relation to Size of CTG Repeat Expansion
JAMA 274:813-819, Tokgozoglu,L.S.,et al, 1995
Mitochondrial DNA and Disease
NEJM 333:638-644, Johns,D.R., 1995
Value of Clinical Hx of Differentiation of Syncope Due to Ventricular Tachycardia, A-V Block & Neurocardiogenic Syncope
Am J Med 98:365-373, Calkins,H.,et al, 1995
Myotonic Dystrophy
In Myology, Engel & Franzini-Armstrong, McGraw-Hill, Inc, New York V2, Ch 43, P1192, Harper,P.S.&Rudel,R., 1994
Cardiovasc Causes of Loss of Consciousness in Pts with Presumed Epilepsy:Cause of Incr Sudden Death in Epilepsy?
Am J Med 96:146-154, Linzer,M.,et al, 1994
Syncope After Eating
NEJM 328:1572, Schima,W.,et al, 1993
Leber's Hereditary Optic Neuropathy as a Cause of Severe Visual Loss in Childhood
Pediatrics 91:988-989, Moorman,C.M.&Elston,J.S., 1993
Sudden Death of a Carrier of X-Linked Emery-Dreifuss Muscular Dystrophy
Ann Int Med 119:900-905, Fishbein,M.C.,et al, 1993
Carbamazepine-Induced Heart Block in Child with Tuberous Sclerosis & Cardiac Rhabdomyoma:Implic for Eval and Follow-up
Ann neurol 34:617-619, Weig,S.G.&Pollack,P., 1993
The Heart in Myotonic Dystrophy
Editorial, Lancet 339:528-5291992., , 1992
Carbamazepine-Induced Cardiac Dysfunction, Characterization of Two Distinct Clinical Syndromes
Arch Int Med 152:186-191, Kasarskis,E.J.,et al, 1992
Clinicopath Conf
Emery-Dreifus Muscular Dystrophy, NEJM 327:548-5571992., , 1992
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
NEJM 325:1487-1498, Dalakas,M.C., 1991